SAN DIEGO, CA — January 28, 2026 — Leads & Copy — Quantumzyme Corp. (OTC: QTZM) plans to attend the 2026 BIO International Convention in San Diego, California, from June 22–25, 2026.
Quantumzyme, a biotransformation company focused on enzyme-based solutions for pharmaceutical manufacturing, said representatives expect to attend the conference and engage in informal networking meetings with industry participants. The company said it will not be presenting, exhibiting, sponsoring, or formally participating in conference programming.
According to Quantumzyme Corp. CEO Naveen Kulkarni, the BIO International Convention is an important opportunity to connect with peers across the biotechnology and biomanufacturing ecosystem. He added that Quantumzyme’s attendance is focused on listening, learning, and engaging in informal discussions with industry participants as the company continues to evaluate developments relevant to its technology and long-term objectives.
The BIO International Convention is a global gathering of biotechnology and life sciences companies, academic institutions, and industry participants representing scientific and commercial disciplines.
Quantumzyme’s attendance is limited to observation and networking activities and is consistent with the company’s efforts to increase industry awareness and maintain dialogue with potential collaborators, technology partners, and other stakeholders. Quantumzyme said there can be no assurance that discussions initiated during the conference will result in any agreements, transactions, or future business relationships.
Quantumzyme Corp. is focused on advancing sustainable enzyme-based solutions for pharmaceutical manufacturing, specializing in green chemistry and applying quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support environmentally responsible production. The company aims to deliver scalable, cost-effective biocatalysis solutions that improve industrial sustainability by integrating computational modeling with laboratory validation.
Additional information regarding the BIO International Convention is available at https://convention.bio.org.
Source: Quantumzyme Corp.
